February 2016 - Biowebspin | Biowebspin
Logo Biowebspin

Archives February 2016 - Biowebspin

DNA tags help the hunt for drugs

DNA tags help the hunt for drugs

  Biowebspin, February 26th, 2016 DNA tags help the hunt for drugs by Asher Mullard, in Nature, 2016 Nestled in a plastic box, in an ordinary laboratory freezer on the second floor of a concrete building in Waltham, Massachusetts, is a clear test tube that contains a concoction of astronomical proportions. The library frozen within, a collection of chemical compounds owned by London-based pharmace... »

Regional systems of innovation: lessons from the biotechnology clusters in Belgium and Germany

Regional systems of innovation: lessons from the biotechnology clusters in Belgium and Germany

  Biowebspin, February 22th, 2016 Regional systems of innovation: lessons from the biotechnology clusters in Belgium and Germany by Jean-Pierre Segers, in Journal of Small Business & Entrepreneurship, 2016 Prior research shows that innovation performance is linked to system, collaboration and networking. There is a growing attention for open innovation. However, the interplay between regional ... »

Sweden

Open innovation in SMEs: a study of the Swedish bio-pharmaceutical industry

  Biowebspin, February 19th, 2016 Open innovation in SMEs: a study of the Swedish bio-pharmaceutical industry by Björn Remneland Wikhamn, Wajda Wikhamn & Alexander Styhre, in Journal of Small Business & Entrepreneurship, 2016 The purpose of this paper is to discuss how small and middle-sized enterprises (SMEs) utilize open innovation in practice. Open innovation has become a well-used rhet... »

Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?

Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?

  Biowebspin, January 15th, 2016 Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D? by Nick Hird, Samik Ghosh, Hiroaki Kitano, in Drug Discovery Today, 2016 The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fiel... »

blog-stethoscope

Open Innovation Networks in Indian Pharmaceutical Sector

  Biowebspin, February 04th, 2016 Open Innovation Networks in Indian Pharmaceutical Sector by Bhawani Bhatnagar, Viktor Dörfler, Jillian MacBryde The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical se... »